Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q2 2025 (June 30)3holders +1
1new positions
0sold out
$1.25avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were State of Wisconsin Investment Board ($2.5M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.5M) and Bank of New York Mellon Corp ($376K).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.5M |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 2,000,001 shares bought, net +2,000,001 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| State of Wisconsin Investment Board | 0.01% | New | 2,000,000 | $2.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +0.0% | 2,000,000 | $2.5M |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $376K |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.